ID,MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,INTERACTION
L65-293,Rabeprazole,CYP2C19,"Minor â€“ result should be considered as may affect medicationresponse",NA
L65-293,Quetiapine,CYP3A4,Usual prescribing considerations apply,NA
L65-293,Timolol (component of Azarga),CYP2D6,Usual prescribing considerations apply,NA
L65-293,fluorometholone,NA,NO,NA
L65-293, brimonidine,NA,NO,NA
L65-293, brinzolamide (component of Azarga),NA,NO,NA
